158 related articles for article (PubMed ID: 7695889)
1. Pathoanatomical aspects of malignant haematological disorders among Danish patients exposed to thorium dioxide.
Visfeldt J; Andersson M
APMIS; 1995 Jan; 103(1):29-36. PubMed ID: 7695889
[TBL] [Abstract][Full Text] [Related]
2. Leukemia and other related hematological disorders among Danish patients exposed to Thorotrast.
Andersson M; Carstensen B; Visfeldt J
Radiat Res; 1993 May; 134(2):224-33. PubMed ID: 8488256
[TBL] [Abstract][Full Text] [Related]
3. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
[TBL] [Abstract][Full Text] [Related]
4. The incidence of secondary leukemias.
Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
[TBL] [Abstract][Full Text] [Related]
5. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
[TBL] [Abstract][Full Text] [Related]
6. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
[TBL] [Abstract][Full Text] [Related]
7. Statistical analysis of Japanese Thorotrast-administered autopsy cases--1980.
Mori T; Kato Y; Aoki N; Hatakeyama S
Health Phys; 1983; 44 Suppl 1():281-92. PubMed ID: 6575000
[TBL] [Abstract][Full Text] [Related]
8. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA
J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208
[TBL] [Abstract][Full Text] [Related]
9. Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease.
Tebbi CK; London WB; Friedman D; Villaluna D; De Alarcon PA; Constine LS; Mendenhall NP; Sposto R; Chauvenet A; Schwartz CL
J Clin Oncol; 2007 Feb; 25(5):493-500. PubMed ID: 17290056
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological study of hematological disorders after Thorotrast administration in Japan.
Kamiyama R; Ishikawa Y; Hatakeyama S; Mori T; Sugiyama H
Blut; 1988 Apr; 56(4):153-60. PubMed ID: 3162698
[TBL] [Abstract][Full Text] [Related]
11. Japanese patients with leukaemia following the use of Thorotrast including a patient with marked chromosomal rearrangements.
Sadamori N; Miyajima J; Okajima S; Shima M; Yano M; Koga M; Kawamoto M; Fujii H; Mori T; Ichimaru M
Acta Haematol; 1987; 77(1):11-4. PubMed ID: 3107315
[TBL] [Abstract][Full Text] [Related]
12. Geographical variation in the incidence of the leukemias and lymphomas.
Weiss NS
Natl Cancer Inst Monogr; 1979 Nov; (53):139-42. PubMed ID: 295090
[TBL] [Abstract][Full Text] [Related]
13. The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001.
Hsu WL; Preston DL; Soda M; Sugiyama H; Funamoto S; Kodama K; Kimura A; Kamada N; Dohy H; Tomonaga M; Iwanaga M; Miyazaki Y; Cullings HM; Suyama A; Ozasa K; Shore RE; Mabuchi K
Radiat Res; 2013 Mar; 179(3):361-82. PubMed ID: 23398354
[TBL] [Abstract][Full Text] [Related]
14. Cancer incidence among Danish Thorotrast-exposed patients.
Andersson M; Storm HH
J Natl Cancer Inst; 1992 Sep; 84(17):1318-25. PubMed ID: 1495101
[TBL] [Abstract][Full Text] [Related]
15. Effects of preconceptional irradiation on mortality and cancer incidence in the offspring of patients given injections of Thorotrast.
Andersson M; Juel K; Ishikawa Y; Storm HH
J Natl Cancer Inst; 1994 Dec; 86(24):1866-7. PubMed ID: 7619110
[TBL] [Abstract][Full Text] [Related]
16. Age-related incidence and other epidemiological aspects of myelodysplastic syndromes.
Aul C; Gattermann N; Schneider W
Br J Haematol; 1992 Oct; 82(2):358-67. PubMed ID: 1419819
[TBL] [Abstract][Full Text] [Related]
17. Cancer in relatives of children with myelodysplastic syndrome, acute and chronic myeloid leukaemia.
Hasle H; Olsen JH
Br J Haematol; 1997 Apr; 97(1):127-31. PubMed ID: 9136952
[TBL] [Abstract][Full Text] [Related]
18. The german thorotrast study: recent results and assessment of risks.
van Kaick G; Dalheimer A; Hornik S; Kaul A; Liebermann D; Lührs H; Spiethoff A; Wegener K; Wesch H
Radiat Res; 1999 Dec; 152(6 Suppl):S64-71. PubMed ID: 10564940
[TBL] [Abstract][Full Text] [Related]
19. Mortality after radiological investigation with radioactive Thorotrast: a follow-up study of up to fifty years in Portugal.
dos Santos Silva I; Malveiro F; Jones ME; Swerdlow AJ
Radiat Res; 2003 Apr; 159(4):521-34. PubMed ID: 12643797
[TBL] [Abstract][Full Text] [Related]
20. Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients.
Armitage JO; Carbone PP; Connors JM; Levine A; Bennett JM; Kroll S
J Clin Oncol; 2003 Mar; 21(5):897-906. PubMed ID: 12610191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
